Filing Flows › Envoy Medical (COCH) › Q2 2025
Envoy Medical (COCH) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 31, 2025
Envoy Medical (COCH) reported revenue of $78K for the second quarter 2025 (Q2 2025), +15% from a year earlier and +70% from the quarter before.
Envoy Medical, Q2 2025: revenue $78K (+15% year over year), net loss $5.7M, operating cash flow −$4.5M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $78K | +70% | +15% |
| Operating profit | −$5.1M | — | — |
| Net earnings | −$5.7M | — | — |
| Operating cash flow | −$4.5M | — | — |
What changed
Revenue was $78K in Q2 2025, up 15% year over year and up 70% from the previous quarter.
Operating costs exceeded revenue by $5.1M, an operating margin of -6500.0%. Total costs grew 5% against revenue growth of 15%. The fastest-growing cost line was General & admin (+30%). The quarter ended with a net loss of $5.7M, wider than the previous quarter's $5.0M loss.
Operating cash flow was −$4.5M. Non-cash charges added back $85K of depreciation and $146K of share-based compensation. Working capital and other items added $1.0M. Capital expenditures of $1K exceeded it, leaving free cash flow of −$4.5M.
Questions
What was Envoy Medical's revenue in the second quarter 2025?
Envoy Medical (COCH) reported revenue of $78K for the second quarter 2025 (Q2 2025), +15% from a year earlier and +70% from the quarter before.
Source: Envoy Medical 10-Q on SEC EDGAR.